A Network Pharmacological Approach to Explore the Mechanisms of TongXieYaoFang in Inflammatory Bowel Disease
DOI:
https://doi.org/10.1590/s2175-97902022e201157Keywords:
Inflammatory bowel disease, Traditional chinese medicine, TongXieYaoFang, BaiZhuShaoYaoSan, Pharmacological actionsAbstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the intestine, demonstrating an increasing incidence every year. TongXieYaoFang (TXYF) has been used widely in China as a complementary therapy to relieve the symptoms of IBD for hundreds of years. In the present research, a network pharmacology-based approach was used to systematically explore the intrinsic mechanisms of TXYF in IBD at the molecular level. Network pharmacology-based methods, which mainly included database mining, screening of bioactive compounds, target prediction, collection of IBD-related targets, gene enrichment analysis, network construction, and molecular docking, were employed in the present study. Network analysis revealed a total of 108 potential targets derived from 22 component compounds of TXYF, among which 34 targets were common with the IBD-related targets. In the protein-protein interaction (PPI) network, 10 key targets were identified. The gene enrichment analysis suggested that anti-inflammatory processes, such as NF-kappa B signaling pathway and Toll-like receptor signaling pathway, could be the core processes involved in the action of TXYF in IBD. Molecular docking results revealed that three compounds present in TXYF exhibited strong binding affinity for PTGS2. The present study provides novel insights into the molecular mechanisms and network approaches of TXYF action in IBD from a systemic perspective. The potential targets and pathways identified in the present study would assist in further research on the clinical application of TXYF in IBD therapy.
Downloads
References
Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al- Assaf AH, Parmar MY, Ahmed MM. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol. 2013;19(34):5633-5644.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25-29.
Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol . 2016;22(20):4794-4801.
Beard H, Cholleti A, Pearlman D, Sherman W, Loving KA. Applying physics-based scoring to calculate free energies of binding for single amino acid mutations in protein-protein complexes. PLoS One. 2013;8(12):e82849.
Bian Y, Liu P, Zhong J, Hu Y, Fan Y, Zhuang S, et al. Kaempferol inhibits multiple pathways involved in the secretion of inflammatory mediators from lps-induced rat intestinal microvascular endothelial cells. Mol Med Rep. 2019;19(3):1958-1964.
Bian Z, Wu T, Liu L, Miao J, Wong H, Song L, et al. Effectiveness of the chinese herbal formula tongxieyaofang for irritable bowel syndrome: A systematic review. J Altern Complement Med. 2006;12(4):401-407.
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. Cluego: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091-1093.
Bose S, Kim H. Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of rhizoma atractylodis macrocephalae on intestinal barrier function against lipopolysaccharide insult. Evid Based Complement Alternat Med. 2013;2013:363076.
Cai H, Xu Y, Xie L, Duan Y, Zhou J, Liu J, et al. Investigation on spectrum-effect correlation between constituents absorbed into blood and bioactivities of baizhu shaoyao san before and after processing on ulcerative colitis rats by uhplc/q-tof-ms/ms coupled with gray correlation analysis. Molecules. 2019;24(5):940.
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. Cytohubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4(Suppl 4):S11.
Cox DG, Crusius JB, Peeters PH, Bueno-de-Mesquita HB, Pena AS, Canzian F. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. World J Gastroenterol . 2005;11(38):6003-6008.
Dudzinska E, Szymona K, Gil-Kulik P, Chomik P, Swistowska M, Gryzinska M, et al. Imbalance of controlled death in peripheral blood lymphocytes in crohn’s disease and ulcerative colitis. Medicina (Kaunas). 2019;55(6):231.
Feuerstein JD, Papamichael K, Popejoy S, Nadelson A, Lewandowski JJ, Geissler K, et al. Targeted physician education and standardizing documentation improves documented reporting with inflammatory bowel disease quality measures in a large academic and private practice. Dig Dis Sci. 2018;63(1):36-45.
Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, et al. Comprehensive intestinal t helper cell profiling reveals specific accumulation of ifn-γ+il- 17+coproducing cd4+ t cells in active inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(12):2321-2329.
Goodsell DS, Zardecki C, Di Costanzo L, Duarte JM, Hudson BP, Persikova I, et al.. Rcsb protein data bank: Enabling biomedical research and drug discovery. Protein Sci. 2020;29(1):52-65.
Grossi V, Hyams JS, Glidden NC, Knight BE, Young EE. Characterizing clinical features and creating a gene expression profile associated with pain burden in children with inflammatory bowel disease. Inflamm Bowel Dis . 2020;26(8):1283-1290.
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47(7):1750-1759.
He B, Lu C, Wang M, Zheng G, Chen G, Jiang M, et al. Drug discovery in traditional chinese medicine: From herbal fufang to combinatory drugs. Science. 2015;350(6262):S74-S76.
He W, Li Y, Liu M, Yu H, Chen Q, Chen Y, et al. Citrus aurantium l. And its flavonoids regulate tnbs-induced inflammatory bowel disease through anti-inflammation and suppressing isolated jejunum contraction. Int J Mol Sci. 2018;19(10):3057.
Ho SC, Kuo CT. Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (citri reticulatae pericarpium). Food Chem Toxicol. 2014;71:176-182.
Hopkins AL. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682-690.
Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
Jiang WY, Seo GS, Kim YC, Sohn DH, Lee SH. Pf2405, standardized fraction of scutellaria baicalensis, ameliorates colitis in vitro and in vivo. Arch Pharm Res. 2015;38(6):1127-1137.
Kanehisa M, Goto S. Kegg: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27-30.
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. Pubchem substance and compound databases. Nucleic Acids Res . 2016;44(D1):D1202-1213.
Koshland DE. Application of a theory of enzyme specificity to protein synthesis. Proc Natl Acad Sci USA. 1958;44(2):98-104.
Maharshak N, Shenhar-Tsarfaty S, Aroyo N, Orpaz N, Guberman I, Canaani J, et al. Microrna-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis . 2013;19(7):1346-1353.
McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, et al. Systemic toll-like receptor ligands modify b-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis . 2011;17(1):298-307.
Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, et al. Review article: Consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;46(11-12):1037-1053.
Onizawa M, Nagaishi T, Kanai T, Nagano K, Oshima S, Nemoto Y, et al. Signaling pathway via tnf-alpha/nf-kappab in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2009;296(4):G850-859.
Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult crohn’s disease in population- based cohorts. Am J Gastroenterol. 2010;105(2):289-297.
Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez- Sacristán A, Deu-Pons J, Centeno E, et al. Disgenet: A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res . 2017;45(D1):D833-d839.
Probst D, Reymond JL. Exploring drugbank in virtual reality chemical space. J Chem Inf Model. 2018;58(9):1731-1735.
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. Tcmsp: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.
Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673-692.
Salam NK, Adzhigirey M, Sherman W, Pearlman DA. Structure-based approach to the prediction of disulfide bonds in proteins. Protein Eng Des Sel. 2014;27(10):365-374.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504.
Sun Y, Zhao Y, Yao J, Zhao L, Wu Z, Wang Y, et al. Wogonoside protects against dextran sulfate sodium- induced experimental colitis in mice by inhibiting nf-κb and nlrp3 inflammasome activation. Biochem Pharmacol. 2015;94(2):142-154.
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M et al. The string database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res . 2017;45(D1):D362-D368.
te Velde AA, Brüll F, Heinsbroek SE, Meijer SL, Lütjohann D, Vreugdenhil A, et al. Effects of dietary plant sterols and stanol esters with low- and high-fat diets in chronic and acute models for experimental colitis. Nutrients. 2015;7(10):8518-8531.
UniProt Consortium T. Uniprot: The universal protein knowledgebase. Nucleic Acids Res . 2018;46(5):2699.
Wallace JL. Prostaglandin biology in inflammatory bowel disease. Gastroenterol Clin North Am. 2001;30(4):971-980.
Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV. Il-6 induces nf-kappa b activation in the intestinal epithelia. J Immunol. 2003;171(6):3194-3201.
Xu YY, Cai H, Duan Y, Pei K, Fan KL, Liu X, et al. [Research progress of baizhu shaoyao powder in treating ulcerative colitis]. Zhongguo Zhong Yao Za Zhi. 2017;42(5):856-862.
Yu G, Wang LG, Han Y, He QY. Clusterprofiler: An r package for comparing biological themes among gene clusters. Omics. 2012;16(5):284-287.
Yu Y, Zheng Z. Protein complex identification based on weighted ppi network with multi-source information. J Theor Biol. 2019;477:77-83.
Zhang YZ, Li YY. Inflammatory bowel disease: Pathogenesis. World J Gastroenterol . 2014;20(1):91-99.
Zhao X, Zheng X, Fan TP, Li Z, Zhang Y, Zheng J. A novel drug discovery strategy inspired by traditional medicine philosophies. Sci. 2015;347(6219):S38-S40.
Zhou Y, Han S, He Y. Clinical effects and safety of tongxieyaofang on diarrhea predominant irritable bowel syndrome: A meta-analysis of randomized trails. Evid Based Complement Alternat Med . 2019;2019:4893876.
Zhu K, Day T, Warshaviak D, Murrett C, Friesner R, Pearlman D. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins. 2014;82(8):1646-1655.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
